Results 121 to 130 of about 24,238,809 (267)
Neurofibromatosis, which was first described in 1882 by Von Recklinghausen, is a genetic disease characterized by a neuroectodermal abnormality and by clinical manifestations of systemic and progressive involvement which mainly affect the skin, nervous ...
João Roberto Antônio +2 more
doaj
La neurofibromatosis (NF) comprende un grupo de enfermedades genéticas de herencia autosómica dominante, que se clasifican de la siguiente manera: neurofibromatosis tipo 1 (NF1), neurofibromatosis tipo 2 (NF2) y schwannomatosis (también conocida como ...
María Florencia Correa +1 more
doaj
Neurofibromatosis type 1 is an autosomal dominant disorder. The vasculopathy of neurofibromatosis type 1 may rarely comprise stenosis, occlusion, aneurysm, pseudoaneurysm, and arteriovenous deformity, and it often presents as rupture of an undiagnosed ...
Jisun Lee, Yook Kim
doaj +1 more source
Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis Type 1 Patient
Sudarsono Sudarsono +5 more
openalex +1 more source
The effect of post-injection 18F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1 [PDF]
Eitan Lovat +5 more
openalex +1 more source
Developmental Medicine &Child Neurology, Volume 68, Issue 2, Page 295-296, February 2026.
Brian Snyder
wiley +1 more source
Background Neurofibromatosis type 1 is a neurocutaneous genetic disorder caused by mutations in the NF1 gene, resulting in the formation of benign tumors called neurofibromas.
Imen Sassi +4 more
doaj +1 more source
Cognitive dysfunction, gait, and motor impairment in neurofibromatosis type 1 [PDF]
Barbara Johnson
openalex +1 more source

